Basal Cell Adhesion Molecule (BCAM) Promotes Mesothelial-to-mesenchymal Transition and Tumor Angiogenesis Through Paracrine Signaling

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Specialties Biochemistry
Cell Biology

Date 2025 Mar 14

PMID 40082910

Authors

Suresh Sivakumar

Sonja Lieber

Raimund Dietze

Vanessa M Beutgen

Eileen C Sutor

Sophie Heidemann

Florian Finkernagel

Julia Teply-Szymanski

Andrea Nist

Thorsten Stiewe

Katrin Roth

Silke Reinartz

Johannes Graumann

Sabine Muller-Brusselbach

Rolf Muller

Affiliations

Soon will be listed here.

Abstract

Background: High expression of basal cell adhesion molecule (BCAM) is a hallmark of ovarian cancer (OC) progression. BCAM facilitates transcoelomic dissemination by promoting mesothelial cell clearance at peritoneal attachment sites of tumor cell spheroids. We investigated how BCAM mediates this effect and potentially drives other pro-metastatic functions.

Methods: The impact of BCAM on the tumor cell secretome and the mesothelial cell phenotype was analyzed by affinity proteomics, bulk and single-cell RNA sequencing, life-cell and multiphoton microscopy, biochemical and functional in vitro assays as well as a murine tumor model. BCAM manipulation involved ectopic overexpression, inducible expression and treatment with soluble BCAM.

Results: All forms of BCAM enhanced the secretion of cytokines that impact cell motility, mesenchymal differentiation and angiogenesis, including AREG, CXCL family members, FGF2, TGFB2, and VEGF. Notably, their levels in OC ascites were correlated with BCAM expression, and recombinant BCAM-induced cytokines triggered mesothelial-mesenchymal transition (MMT). Mesothelial cells undergoing MMT exhibited enhanced motility away from attaching tumor spheroids, leading to mesothelial clearance at spheroid attachment sites. BCAM-mediated MMT-associated transcriptional changes were also observed in subpopulations of omental mesothelial cells from OC patients, and were associated with poor survival. Consistent with the secretome data, BCAM induced endothelial tube formation in vitro and markedly promoted tumor angiogenesis in a mouse model.

Conclusion: We have identified previously unknown functions of the BCAM-induced secretome potentially impacting distinct stages of OC metastasis. While BCAM's impact on MMT may facilitate initiation of micrometastases, neo-angiogenesis is essential for tumor growth. Taken together with the observed clinical adverse association, our findings underscore the potential of BCAM as a therapeutic target.

References

Eyler C, Telen M . The Lutheran glycoprotein: a multifunctional adhesion receptor. Transfusion. 2006; 46(4):668-77. DOI: 10.1111/j.1537-2995.2006.00779.x. View

Finkernagel F, Reinartz S, Schuldner M, Malz A, Jansen J, Wagner U . Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment. Theranostics. 2019; 9(22):6601-6617. PMC: 6771240. DOI: 10.7150/thno.37549. View

Rahuel C, Le Van Kim C, Mattei M, Cartron J, Colin Y . A unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood. 1996; 88(5):1865-72. View

Niiya D, Egawa N, Sakamoto T, Kikkawa Y, Shinkawa T, Isobe T . Identification and characterization of Lutheran blood group glycoprotein as a new substrate of membrane-type 1 matrix metalloproteinase 1 (MT1-MMP): a systemic whole cell analysis of MT1-MMP-associating proteins in A431 cells. J Biol Chem. 2009; 284(40):27360-9. PMC: 2785664. DOI: 10.1074/jbc.M109.029124. View

Sivakumar S, Lieber S, Librizzi D, Keber C, Sommerfeld L, Finkernagel F . Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer. Clin Transl Med. 2023; 13(1):e1176. PMC: 9842900. DOI: 10.1002/ctm2.1176. View

Udani M, Zen Q, Cottman M, Leonard N, JEFFERSON S, Daymont C . Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest. 1998; 101(11):2550-8. PMC: 508844. DOI: 10.1172/JCI1204. View

Zen Q, Cottman M, Truskey G, Fraser R, Telen M . Critical factors in basal cell adhesion molecule/lutheran-mediated adhesion to laminin. J Biol Chem. 1999; 274(2):728-34. DOI: 10.1074/jbc.274.2.728. View

Parsons S, Lee G, Spring F, Willig T, Peters L, Gimm J . Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity. Blood. 2001; 97(1):312-20. DOI: 10.1182/blood.v97.1.312. View

Kikkawa Y, Sasaki T, Nguyen M, Nomizu M, Mitaka T, Miner J . The LG1-3 tandem of laminin alpha5 harbors the binding sites of Lutheran/basal cell adhesion molecule and alpha3beta1/alpha6beta1 integrins. J Biol Chem. 2007; 282(20):14853-60. DOI: 10.1074/jbc.M611706200. View

10.

Wautier M, El Nemer W, Gane P, Rain J, Cartron J, Colin Y . Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM. Blood. 2007; 110(3):894-901. DOI: 10.1182/blood-2006-10-048298. View

11.

Kikkawa Y, Ogawa T, Sudo R, Yamada Y, Katagiri F, Hozumi K . The lutheran/basal cell adhesion molecule promotes tumor cell migration by modulating integrin-mediated cell attachment to laminin-511 protein. J Biol Chem. 2013; 288(43):30990-1001. PMC: 3829412. DOI: 10.1074/jbc.M113.486456. View

12.

Akiyama H, Iwahana Y, Suda M, Yoshimura A, Kogai H, Nagashima A . The FBI1/Akirin2 target gene, BCAM, acts as a suppressive oncogene. PLoS One. 2013; 8(11):e78716. PMC: 3819372. DOI: 10.1371/journal.pone.0078716. View

13.

Chang H, Chang H, Wu T, Chaing C, Tzai T, Cheng H . The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis. J Biomed Sci. 2017; 24(1):61. PMC: 6389174. DOI: 10.1186/s12929-017-0360-x. View

14.

Guadall A, Cochet S, Renaud O, Colin Y, Le Van Kim C, de Brevern A . Dimerization and phosphorylation of Lutheran/basal cell adhesion molecule are critical for its function in cell migration on laminin. J Biol Chem. 2019; 294(41):14911-14921. PMC: 6791331. DOI: 10.1074/jbc.RA119.007521. View

15.

Jin J, Xie S, Sun Q, Huang Z, Chen K, Guo D . Upregulation of BCAM and its sense lncRNA BAN are associated with gastric cancer metastasis and poor prognosis. Mol Oncol. 2020; 14(4):829-845. PMC: 7138403. DOI: 10.1002/1878-0261.12638. View

16.

Kenny H, Nieman K, Mitra A, Lengyel E . The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer. Cancer Discov. 2011; 1(2):100-2. PMC: 3193939. DOI: 10.1158/2159-8290.CD-11-0117. View

17.

Burleson K, Hansen L, Skubitz A . Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin Exp Metastasis. 2005; 21(8):685-97. DOI: 10.1007/s10585-004-5768-5. View

18.

Lyu Y, Feng C . Collagen synthesis and gap junctions: the highway for metastasis of ovarian cancer. Lab Invest. 2021; 101(5):540-542. DOI: 10.1038/s41374-021-00546-0. View

19.

Sarwar M, Sykes P, Chitcholtan K, Evans J . Collagen I dysregulation is pivotal for ovarian cancer progression. Tissue Cell. 2021; 74:101704. DOI: 10.1016/j.tice.2021.101704. View

20.

Godavarthy P, Walter C, Lengerke C, Klein G . The Laminin Receptors Basal Cell Adhesion Molecule/Lutheran and Integrin α7β1 on Human Hematopoietic Stem Cells. Front Cell Dev Biol. 2021; 9:675240. PMC: 8570280. DOI: 10.3389/fcell.2021.675240. View